Cargando…

Serum Calprotectin Levels and Outcome Following Percutaneous Coronary Intervention in Patients with Diabetes and Acute Coronary Syndrome

BACKGROUND: A retrospective study of data from a prospective clinical registry was conducted to evaluate the prognostic role of serum calprotectin in patients with diabetes who underwent percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). MATERIAL/METHODS: Data were retrieved...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Chengji, Kong, Yu, Ding, Yuanyuan, Sun, Jingzhi, Chen, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2019
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929552/ https://www.ncbi.nlm.nih.gov/pubmed/31834876 http://dx.doi.org/10.12659/MSM.918126

Ejemplares similares

Prognostic value of serum calprotectin level in elderly diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: A Cohort study
por: Zhang, Wutang, et al.
Publicado: (2020)

Changes in serum serotonin levels in patients with acute coronary syndrome and stable angina undergoing percutaneous coronary intervention
por: Han, Donghoon, et al.
Publicado: (2020)

Safety and cost analysis of early discharge following percutaneous coronary intervention for acute coronary syndrome in patients with diabetes mellitus
por: Li, Shihong, et al.
Publicado: (2019)

Association between Serum Ferritin and Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Zhu, Boqian, et al.
Publicado: (2016)

Correlation between serum free triiodothyronine levels and risk stratification in Chinese patients with acute coronary syndrome receiving percutaneous coronary intervention
por: Li, Huiying, et al.
Publicado: (2020)

Prognostic Value of Hemoglobin A1c Levels in Postmenopausal Diabetic Patients Undergoing Percutaneous Coronary Intervention (PCI) for Acute Coronary Syndrome
por: Lao, Yi, et al.
Publicado: (2018)

Two-Year Outcomes after Left Main Coronary Artery Percutaneous Coronary Intervention in Patients Presenting with Acute Coronary Syndrome
por: Jia, Si-Da, et al.
Publicado: (2020)

Unprotected Left Main Percutaneous Coronary Intervention in Acute Coronary Syndromes with Extracorporeal Life Support Backup
por: Staudacher, Dawid L., et al.
Publicado: (2015)

Eccentric hypertrophy predicts adverse events in patients undergoing percutaneous coronary intervention for acute coronary syndrome
por: Ha, Edward T., et al.
Publicado: (2021)

Altered serum creatine kinase level and cardiac function in ischemia-reperfusion injury during percutaneous coronary intervention
por: Luo, Yi, et al.
Publicado: (2011)

Serum VEGF Predicts Worse Clinical Outcome of Patients with Coronary Heart Disease After Percutaneous Coronary Intervention Therapy
por: Han, Xia, et al.
Publicado: (2015)

Intracoronary administration of tirofiban during percutaneous coronary intervention facilitates patients with acute coronary syndrome
por: Jia, Helei, et al.
Publicado: (2017)

Evaluation of the Prognostic Role of the Wall Motion Score Index and the SYNTAX Score II in Patients with Acute Coronary Syndrome Following Percutaneous Coronary Intervention by Evaluation of Major Adverse Cardiovascular Events at 12-Month Follow-Up
por: Kong, Fanyang, et al.
Publicado: (2021)

Case report: Takotsubo syndrome following percutaneous coronary intervention
por: Lu, Rui, et al.
Publicado: (2023)

Combination of D-dimer level and neutrophil to lymphocyte ratio predicts long-term clinical outcomes in acute coronary syndrome after percutaneous coronary intervention
por: Gu, Ling-Feng, et al.
Publicado: (2023)

Neutrophil-derived microparticles are released into the coronary circulation following percutaneous coronary intervention in acute coronary syndrome patients
por: Martínez, Gonzalo J., et al.
Publicado: (2017)

Prognostic value of peripheral blood inflammatory cell subsets in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Gao, Xiuxin, et al.
Publicado: (2021)

Serum lipoprotein(a) and risk of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention
por: Huang, Zhuoshan, et al.
Publicado: (2020)

Long-term outcomes of percutaneous coronary interventions within coronary artery bypass grafts
por: Januszek, Rafał, et al.
Publicado: (2019)

Implications of bleeding in acute coronary syndrome and percutaneous coronary intervention
por: Pham, Phuong-Anh, et al.
Publicado: (2011)

The relationship between IL-6 levels and the angiographic severity of coronary artery disease following percutaneous coronary intervention in acute coronary syndrome patients
por: Ling, Yang, et al.
Publicado: (2021)

Prognostic Value of Serum Total Bilirubin after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome
por: Tang, Chengchun, et al.
Publicado: (2019)

Clinical effect of ticagrelor administered in acute coronary syndrome patients following percutaneous coronary intervention
por: LU, YANJIAO, et al.
Publicado: (2016)

Baseline Serum Uric Acid Levels Are Associated with All-Cause Mortality in Acute Coronary Syndrome Patients after Percutaneous Coronary Intervention
por: Ye, Ziliang, et al.
Publicado: (2018)

The effect of cardiac geometry variation according to sex and race on outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Ha, Edward T., et al.
Publicado: (2021)

Use of cangrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Study design and interim analysis of the ARCANGELO study
por: De Luca, Leonardo, et al.
Publicado: (2022)

Percutaneous coronary intervention following Fontan procedure
por: Subahi, Ahmed, et al.
Publicado: (2020)

Chronic left atrial pseudoaneurysm caused by coronary artery perforation during percutaneous coronary intervention
por: Corballis, Natasha, et al.
Publicado: (2018)

Coronary artery lesion distribution in patients with chronic kidney disease undergoing percutaneous coronary intervention
por: Ikeda, Naofumi, et al.
Publicado: (2022)

Relationship between serum interleukin-6 levels and severity of coronary artery disease undergoing percutaneous coronary intervention
por: Bouzidi, Nadia, et al.
Publicado: (2023)

For patients with prior coronary artery bypass grafting and recurrent myocardial ischemia, percutaneous coronary intervention on bypass graft or native coronary artery?—A 5‐year follow‐up cohort study
por: Liu, Ru, et al.
Publicado: (2023)

Predictive value of cardiopulmonary fitness parameters in the prognosis of patients with acute coronary syndrome after percutaneous coronary intervention
por: Niu, Suping, et al.
Publicado: (2020)

Heightened risk of cardiac events following percutaneous coronary intervention for cocaine-associated myocardial infarction
por: Chen, Ching Wei Russell, et al.
Publicado: (2019)

Retrospective Study of Clinical and Epidemiological Parameters of Patients Undergoing Percutaneous Coronary Intervention with Their Follow-Up
por: Parikh, Rohan P., et al.
Publicado: (2019)

Percutaneous coronary intervention in patients with acute coronary syndrome: focus on bivalirudin
por: Ramana, Ravi K, et al.
Publicado: (2008)

Comparison of Coronary Artery Bypass Graft-First and Percutaneous Coronary Intervention-First Approaches for 2-Stage Hybrid Coronary Revascularization
por: Choi, Hang Jun, et al.
Publicado: (2017)

Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome
por: Chen, Shih-Chin, et al.
Publicado: (2014)

Prognostic Value of VEGF in Patients Submitted to Percutaneous Coronary Intervention
por: Ramos, Catarina, et al.
Publicado: (2014)

Fracture guide wire during an elective percutaneous coronary intervention
por: Samanidis, George, et al.
Publicado: (2017)

Emergency Percutaneous Coronary Intervention Through the Left Radial Artery is Associated with Less Vascular Complications than Emergency Percutaneous Coronary Intervention Through the Femoral Artery
por: Qi, Guoqing, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ggkka31o6i57qbjpgruk7j5ki6